AHC Ballana Heart Study
- Conditions
- Genetic Predisposition to Disease
- Interventions
- Other: Risk assessment
- Registration Number
- NCT05661318
- Lead Sponsor
- Magdi Yacoub Heart Foundation
- Brief Summary
This Study is designed to assess CVD incidence, prevalence, progression and related risk factors, including genetic background. It will provide an important base for all cardiovascular research activities in our centre and help in designing future studies and guide policy.
- Detailed Description
Background Population-based longitudinal studies are a cornerstone in understanding current disease landscapes affecting communities and collecting reliable data to guide prevention and treatment strategies. In Egypt there is pressing need of collecting reliable data on cardiovascular disease (CVD) in defined populations.
Objectives Defining the cardiovascular phenotype, genotype as well as OMICS and risk factors for CVD in a defined population in Egypt with follow up for up to 30 years
Methods As a first step, a random representative sample of 1,200 households from the Ballana population will be created. Following inclusion, patients will be screened for their cardiovascular profile and followed up for changes in their profile and cardiovascular events continuously every year in high risk patients and every 3 years for the rest of the participants for a period of 30 years.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 5000
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description BHS Risk assessment Residents of Ballana from the 1,200 randomly selected households
- Primary Outcome Measures
Name Time Method Cardiovascular risk assessment 30 years
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Aswan Heart Centre - Magdi Yacoub Heart Foundation
🇪🇬Aswan, Egypt